Publicaciones en las que colabora con FERNANDO RODRÍGUEZ SERRANO (35)

2012

  1. How is gene transfection able to improve current chemotherapy? The role of combined therapy in cancer treatment

    Current Medicinal Chemistry, Vol. 19, Núm. 12, pp. 1870-1888

  2. The selective cytotoxic activity in breast cancer cells by an anthranilic alcohol-derived acyclic 5-fluorouracil O,N-acetal is mediated by endoplasmic reticulum stress-induced apoptosis

    European Journal of Medicinal Chemistry, Vol. 50, pp. 376-382

  3. Treatment of heart disease: Use of transdifferentiation methodology for reprogramming adult stem cells

    Stem Cells and Cancer Stem Cells, Volume 2: Stem Cells and Cancer Stem Cells, Therapeutic Applications in Disease and Injury: Volume 2 (Springer Netherlands), pp. 169-183

2011

  1. Anticancer activity and cDNA microarray studies of a (RS)-1,2,3,5- tetrahydro-4,1-benzoxazepine-3-yl]-6-chloro-9H-purine, and an acyclic (RS)-O,N-acetalic 6-chloro-7H-purine

    European Journal of Medicinal Chemistry, Vol. 46, Núm. 9, pp. 3802-3809

  2. Development of patents and clinical trials on regenerative therapy: Gene therapy

    Recent Patents on Regenerative Medicine, Vol. 1, Núm. 2, pp. 182-194

  3. Nanomedicine: Application areas and development prospects

    International Journal of Molecular Sciences, Vol. 12, Núm. 5, pp. 3303-3321

  4. New (RS)-benzoxazepin-purines with antitumour activity: The chiral switch from (RS)-2,6-dichloro-9-[1-(p-nitrobenzenesulfonyl)-1,2,3,5-tetrahydro-4,1- benzoxazepin-3-yl]-9H-purine

    European Journal of Medicinal Chemistry, Vol. 46, Núm. 1, pp. 249-258

  5. Regenerative therapies in cartilage and bone: Current patents, technologies, and emerging applications

    Recent Patents on Regenerative Medicine, Vol. 1, Núm. 2, pp. 134-141

  6. Therapeutic Approaches in Regenerative Medicine of Cardiovascular Diseases: From Bench to Bedside

    ADVANCES IN REGENERATIVE MEDICINE (INTECH EUROPE), pp. 61-88

  7. Transdifferentiation: why and how?

    Cell biology international, Vol. 35, Núm. 4, pp. 373-379

  8. Ultrastructural and molecular analyzes of insulin-producing cells induced from human hepatoma cells

    Cytotherapy, Vol. 13, Núm. 2, pp. 193-200

2010

  1. Differentiation of intestinal epithelial cells mediated by cell confluence and/or exogenous nucleoside supplementation

    Cells Tissues Organs, Vol. 191, Núm. 6, pp. 478-488

  2. Promotion of human adipose-derived stem cell proliferation mediated by exogenous nucleosides

    Cell Biology International, Vol. 34, Núm. 9, pp. 917-924

2009

  1. Cell surface immobilization of GABAARs in cerebellar granule cells depends on the M3/M4 cytoplasmatic loop of the alpha 1 subunit

    Cells Tissues Organs, Vol. 189, Núm. 6, pp. 420-424

2008

  1. Anticancer activity of (1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl)-pyrimidines and -purines against the MCF-7 cell line: Preliminary cDNA microarray studies

    Bioorganic and Medicinal Chemistry Letters, Vol. 18, Núm. 4, pp. 1457-1460

  2. Regiospecific microwave-assisted synthesis and cytotoxic activity against human breast cancer cells of (RS)-6-substituted-7- or 9-(2,3-dihydro-5H-1,4-benzodioxepin-3-yl)-7H- or -9H-purines

    European Journal of Medicinal Chemistry, Vol. 43, Núm. 8, pp. 1742-1748

  3. Synthesis and anticancer activity of (R,S)-9-(2,3-dihydro-1,4-benzoxathiin- 3-ylmethyl)-9H-purines

    ChemMedChem, Vol. 3, Núm. 1, pp. 127-135

  4. Tumour malignancy loss and cell differentiation are associated with induction of gef gene in human melanoma cells

    British Journal of Dermatology, Vol. 159, Núm. 2, pp. 370-378

2007

  1. 5-fluorouracil derivatives induce differentiation mediated by tubulin and HLA class I modulation

    Medicinal Chemistry, Vol. 3, Núm. 3, pp. 233-239

  2. 6′-Chloro-7- or 9-(2,3-dihydro-5H-4,1-benzoxathiepin-3-yl)-7H- or 9H-purines and their corresponding sulfones as a new family of cytotoxic drugs

    Tetrahedron, Vol. 63, Núm. 1, pp. 183-190